Biotechnology Services Market by Service Type, End-Users

List of Tables

The Biotechnology Services Market is projected to reach USD 416.25 billion by 2030 from USD 173.75 billion in 2022, at a CAGR of 11.53% during the forecast period.

Global Biotechnology Services Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 173.75 billion
Estimated Year Value [2023]	USD 193.05 billion
Forecast Year Value [2030]	USD 416.25 billion
CAGR (%)	11.53%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biotechnology Services Market.

Based on Service Type, market is studied across Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services, Prevention & Disease Control, Public Engagement Activities, and Tissue Collection. The Tissue Collection is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Biotechnology Companies, Clinical Research Organizations(CROs), and Contract Manufacturers Organizations (CMOs). The Clinical Research Organizations(CROs) is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biotechnology Services Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biotechnology Services Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Biotechnology Services Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Biotechnology Services Market?

3. What is the competitive strategic window for identifying opportunities in the Biotechnology Services Market?

4. What are the latest technology trends and regulatory frameworks in the Biotechnology Services Market?

5. What is the market share of the leading vendors in the Biotechnology Services Market?

6. Which modes and strategic moves are suitable for entering the Biotechnology Services Market?

Product Code: MRR-521BAA36EA9E

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Biotechnology Services Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing outsourcing of drug development activities by pharmaceutical companies
  - 5.1.1.2. Growing rate of academic research activities and need for efficient facilities
  - 5.1.1.3. Rising expansion of contract research and manufacturing services
- 5.1.2. Restraints
  - 5.1.2.1. Concerns over performance, quality and confidentiality of outsourcing services
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in biotechnology instruments and techniques
  - 5.1.3.2. Emerging funding and investment activities in biotechnology research
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory compliances for biotechnology outsourcing services
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Biotechnology Services Market, by Service Type

6.1. Introduction
6.2. Cell Processing & Isolation
6.3. Donor Recruitment
6.4. Food Biotechnology Services
6.5. Prevention & Disease Control
6.6. Public Engagement Activities
6.7. Tissue Collection

7. Biotechnology Services Market, by End-Users

7.1. Introduction
7.2. Biotechnology Companies
7.3. Clinical Research Organizations(CROs)
7.4. Contract Manufacturers Organizations (CMOs)

8. Americas Biotechnology Services Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Biotechnology Services Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Services Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
- 12.1.1. Agilent Technologies, Inc.
- 12.1.2. Almac Group Limited
- 12.1.3. AnaBioTec NV
- 12.1.4. Avance Clinical Pty Ltd.
- 12.1.5. Azenta Life Sciences
- 12.1.6. Becton, Dickinson and Company
- 12.1.7. Biogen Inc.
- 12.1.8. BioIVT LLC
- 12.1.9. Caidya
- 12.1.10. Catalent, Inc.
- 12.1.11. Charles River Laboratories International, Inc.
- 12.1.12. CMIC Group
- 12.1.13. Contract Pharmacal Corp.
- 12.1.14. Crown Bioscience, Inc.
- 12.1.15. Danaher Corporation
- 12.1.16. Eurofins Scientific Limited
- 12.1.17. GE HealthCare Technologies Inc.
- 12.1.18. GenScript Biotech Corporation
- 12.1.19. ICON PLC
- 12.1.20. ITR Laboratories Canada
- 12.1.21. Kaneka Corporation
- 12.1.22. Laboratory Corporation of America Holdings
- 12.1.23. Merck KGaA
- 12.1.24. Novartis AG
- 12.1.25. Siemens Healthcare GmbH
- 12.1.26. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing